Send feedback

BMPR2 p.Arg873Gln

c.2618G>A · rs201781338 · VCV425999

Benign Expert panel
Classification
Benign
ClinVar
Review
Expert panel ★★★☆
ClinVar · 4 submitters
AlphaMissense
likely benign
0.2661 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0557%, eas)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
2
pulmonary arterial hypertension

ClinGen expert panel — Pulmonary Hypertension VCEP

Benign for pulmonary arterial hypertension. Applied ACMG criteria (verbatim):

BS1 BS4 BS3_Supporting

Curation rationale (ClinGen, verbatim)

The c.2618G>A variant (NM_001204.7) in BMPR2 is a missense variant predicted to cause substitution of arginine by glutamine at amino acid 873 (p.Arg873Gln). The highest population minor allele frequency in gnomAD v2.2.1 controls is 0.001595 in Other East Asian, which is higher than the ClinGen Pulmonary Hypertension VCEP threshold (≥0.001) for BS1 but great than the threshold for BA1 (>05%) (BS1 met). This variant was reported to not segregate with pulmonary arterial hypertension in one affected family member from one family (BS4; Internal PH VCEP member contribution). In vitro reporter system assay in mouse embryonic endothelial cells showed that the c.2618 G>A variant activated BRE-Luc (specific reporter gene for Smad1/5 activation) in response to BMP4 treatment in a similar way as the wild-type BMPR2 reporter gene. However the impairment of another function through an alternative signaling pathway of BMPRII could not be excluded (PMID 25429696)(BS3_Supporting). In summary, this variant meets the criteria to be classified as benign for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP (specification version 2.0, 1/30/2026): BS4, BS1, BS3_Supporting.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.2661likely benign
REVEL0.551indeterminate
SaProtLLR -6.22tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 2.7, phastCons 1
Regional constrainto/e 0.92unconstrained · MANE · 6,896 bp · p 0.061 · regional, not allelic
Overall
CADD26.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0557% East Asian · 25/44,880 alleles
Filtering AF 0.0387% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.033%
Overall 0.00564% 91/1,614,186 alleles · ultra-rare
Ancestry group Frequency 1 in
East Asiangrpmax 0.0557% 1,795
Middle Eastern 0.0165% 6,062
Remaining individualsnot grpmax-eligible 0.0048% 20,837
European (non-Finnish) 0.00475% 21,072
African / African-American 0.004% 25,019
South Asian 0.00329% 30,353

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
BMPR2
Protein
p.Arg873Gln
Coding
c.2618G>A
MANE Select
NM_001204
dbSNP
rs201781338
Type
single nucleotide variant
Location
chr2:202556283 (GRCh38)
Gene constraint
LOEUF 0.376 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 58.07 · 7 PDB
Residue 873
a UniProt-annotated variant site (in pph1; changed localization to the plasma membrane); a UniProt-annotated variant site (in pph1; loss of localization to the plasma membrane; localized to the cytoplasm); the 'disordered' region
Full BMPR2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

pulmonary arterial hypertension — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: pulmonary hypertension, primary, 1

For Idiopathic/heritable pulmonary arterial hypertension (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive, Not applicable
Onset
All ages
Prevalence
1-9 / 1 000 000 (United States)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bmpr2-p-arg873gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown